Share on StockTwits

Cytomedix (NASDAQ:CMXI) Insider Dean Tozer acquired 40,000 shares of Cytomedix stock on the open market in a transaction dated Friday, August 29th. The shares were purchased at an average price of $0.35 per share, with a total value of $14,000.00. Following the transaction, the insider now directly owns 126,700 shares of the company’s stock, valued at approximately $44,345. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Cytomedix (NASDAQ:CMXI) traded up 1.41% on Tuesday, hitting $0.36. The stock had a trading volume of 524,730 shares. Cytomedix has a 1-year low of $0.33 and a 1-year high of $0.68. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.46. The company’s market cap is $44.8 million.

Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.

Receive News & Ratings for Cytomedix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytomedix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.